Type 1 Diabetes Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are 18 years of age or older
• People who have been clinically diagnosed with diabetes mellitus for at least one year
• People who are willing to sign a consent form and follow the study's requirements

Who may not be able to join:

• People who have had a severe low blood sugar episode (one that caused loss of consciousness or a seizure) in the past 6 months
• People who have visited an emergency room or been hospitalised due to diabetic ketoacidosis in the past 6 months
• People who have a condition called gastroparesis (where the stomach empties too slowly)
• Women who are able to become pregnant and are currently pregnant, breastfeeding, planning to become pregnant, or not using birth control during the study period
• People who have a physical condition, upper limb deformity, or skin condition that would interfere with placing, using, or removing the study sensor or wearing its transmitter
• People with certain heart or blood pressure conditions, including: coronary artery disease with symptoms, unstable chest pain, a heart attack, a mini-stroke, or stroke within the past 6 months, uncontrolled high blood pressure at the time of screening, current heart failure, or a history of heart rhythm problems (minor rhythm variations may be allowed). People with coronary artery disease that causes no symptoms may be considered if they have had a negative stress test within the past year and written approval from a heart specialist (confirm with trial site)
• People whose blood thickness (haematocrit) falls outside a specific range at screening (confirm with trial site)
• People with a history of hepatitis B, hepatitis C, or HIV
• People currently being treated for a seizure disorder, unless a neurologist has provided written approval to participate
• People with a history of adrenal insufficiency (a condition where the adrenal glands do not produce enough hormones)
• People currently receiving, or likely to need during the study: immune-suppressing medications, chemotherapy, blood-thinning medications (not including aspirin), steroid creams applied over the sensor site only, or long-term antibiotics for a chronic infection
• People who have a condition that requires or is likely to require an MRI scan
• People with a known allergy to topical or local anaesthetics
• People with a known allergy to glucocorticoids (a type of steroid medication)
• People with any condition that the study doctor believes would make participation unsafe or unsuitable, including certain mental health conditions, recent alcohol or drug misuse, or conditions that may increase the risk of low blood sugar or complications from repeated blood testing
• People who have taken part in another clinical trial (drug or device) within the 2 weeks before screening, or who plan to join another trial during the study period
• People who have an active implanted device (such as an implantable defibrillator). Passive implanted devices (such as a cardiac stent) are permitted. Some continuous glucose monitors are allowed, but the Eversense CGM System (not provided by the study) is not permitted (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.